GUJARAT INJECT (KERALA) LTD. (GUJINJEC.BO)
INR 23.32
(5.0%)
INR 23.32
(5.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 57.88 Million | 1.73 Million | 226 Thousand | 115.5 Thousand | - |
| Cost of Revenue | 54.03 Million | 1.53 Million | 155.23 Thousand | 89.19 Thousand | - |
| Gross Profit | 3.85 Million | 199.26 Thousand | 70.76 Thousand | 26.3 Thousand | - |
| Operating Expenses | 3.85 Million | 3.96 Million | 529.34 Thousand | 1.16 Million | 50.8 Thousand |
| Selling, General and Administrative Expenses | 3.11 Million | 3.69 Million | 386.34 Thousand | 1.13 Million | 19.3 Thousand |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | 741.64 Thousand | 4.32 Million | 482.24 Thousand | 82 Thousand | 53 Thousand |
| Cost and Expenses | 57.88 Million | 5.5 Million | 684.58 Thousand | 1.24 Million | 50.8 Thousand |
| Operating Income | 448.64 Thousand | 554.9 Thousand | 29.49 Thousand | -1.05 Million | 2200.00 |
| Interest Expense | 4000.00 | 501.00 | - | - | - |
| Income Tax Expense | 225 Thousand | 144.44 Thousand | 7400.00 | -206.29 Thousand | -171.86 Thousand |
| Earnings before Tax | 1.05 Million | 554.9 Thousand | 29.49 Thousand | -1.05 Million | 2200.00 |
| Net Income | 827.62 Thousand | 410 Thousand | 22.09 Thousand | -1.05 Million | 2200.00 |
| Earnings Per Share Basic | 0.18 | 0.05 | 0.00 | -0.21 | 0.00 |
| Earnings Per Share Diluted | 0.18 | 0.05 | 0.00 | -0.21 | 0.00 |
| Weighted Average Shares Outstanding | 4.6 Million | 4.89 Million | 4.89 Million | 4.89 Million | 4.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.6 Million | 4.89 Million | 4.89 Million | 4.89 Million | 4.89 Million |
| Gross Margin | 0.07 | 0.11 | 0.31 | 0.23 | - |
| EBIT Margin | 0.02 | 0.32 | 0.13 | -9.11 | - |
| Profit Margin | 0.01 | 0.24 | 0.10 | -9.11 | - |
| EBITDA | 1.05 Million | 554.9 Thousand | 29.49 Thousand | -1.05 Million | 2200.00 |
| Earnings Before Tax Margin | 0.01 | 0.32 | 0.13 | -9.11 | - |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 30.45 Million | 57.88 Million | 54.18 Million | 2.15 Million | - | 1.53 Million |
| Cost of Revenue | 27.65 Million | 54.03 Million | 51.4 Million | 1.53 Million | - | 1.08 Million |
| Gross Profit | 2.8 Million | 3.85 Million | 2.78 Million | 625 Thousand | - | 448 Thousand |
| Operating Expenses | 1.14 Million | 3.4 Million | 2.32 Million | 938 Thousand | 66 Thousand | 76 Thousand |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 608 Thousand | 2000.00 | 374 Thousand | 232 Thousand | - |
| Cost and Expenses | 28.79 Million | 57.43 Million | 53.73 Million | 2.47 Million | 66 Thousand | 1.16 Million |
| Operating Income | 1.65 Million | 1.05 Million | 459 Thousand | 61 Thousand | 166 Thousand | 372 Thousand |
| Interest Expense | 2000.00 | 4000.00 | 4000.00 | - | - | - |
| Income Tax Expense | 430 Thousand | 225 Thousand | 75 Thousand | 15 Thousand | 41 Thousand | 97 Thousand |
| Earnings before Tax | 1.65 Million | 1.05 Million | 455 Thousand | 61 Thousand | 166 Thousand | 372 Thousand |
| Net Income | 1.22 Million | 828 Thousand | 380 Thousand | 46 Thousand | 125 Thousand | 275 Thousand |
| Earnings Per Share Basic | 0.08 | - | 0.08 | 0.01 | 0.03 | 0.06 |
| Earnings Per Share Diluted | 0.08 | - | 0.08 | 0.01 | 0.03 | 0.06 |
| Weighted Average Shares Outstanding | 15.28 Million | 4.6 Million | 4.6 Million | 4.6 Million | 4.16 Million | 4.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.28 Million | 4.6 Million | 4.6 Million | 4.6 Million | 4.16 Million | 4.58 Million |
| Gross Margin | 0.09 | 0.07 | 0.05 | 0.29 | - | 0.29 |
| EBIT Margin | 0.05 | - | 0.01 | 0.03 | - | 0.24 |
| Profit Margin | 0.04 | 0.01 | 0.01 | 0.02 | - | 0.18 |
| EBITDA | 1.65 Million | - | 459 Thousand | 61 Thousand | 166 Thousand | 372 Thousand |
| Earnings Before Tax Margin | 0.05 | 0.02 | 0.01 | 0.03 | - | 0.24 |
CTV-WT
PFFEF
3391
DUNCANENG
ROSEMER
003041